January 26, 2026 article IgA Nephropathy in Adults JAMA DOI: 10.1001/jama.2025.25020 OpenAlex Authors 0 Author list not loaded yet. Cited by 0 stored of 20 References 8 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy 2022 JAMA article Medicine Renal Diseases and Glomerulopathies Open access cited by 1 patent 360 citations Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial 2023 The Lancet article Medicine Renal Diseases and Glomerulopathies Open access 334 citations Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial 2023 The Lancet article Medicine Renal Diseases and Glomerulopathies Open access 305 citations IgA nephropathy 2023 Nature Reviews Disease Primers review Medicine Renal Diseases and Glomerulopathies Open access 246 citations Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy 2022 Kidney International article Medicine Renal Diseases and Glomerulopathies Open access 226 citations KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV) 2025 Kidney International article Medicine Renal Diseases and Glomerulopathies Open access 156 citations Targeted-release budesonide modifies key pathogenic biomarkers in immunoglobulin A nephropathy: insights from the NEFIGAN trial 2023 Kidney International article Medicine Renal Diseases and Glomerulopathies Open access 58 citations A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy 2025 New England Journal of Medicine article Medicine Renal Diseases and Glomerulopathies 51 citations 8 results